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Abstract (Word count: 250) 
Objective: Tumor infiltrating lymphocytes (TILs) favor survival in human colorectal cancer 
(CRC). Chemotactic factors underlying their recruitment remain undefined. We investigated 
chemokines attracting T cells into human CRCs, their cellular sources and micro-
environmental triggers. 
Design: Expression of genes encoding immune cell markers, chemokines, and bacterial 16S 
ribosomal RNA (16SrRNA) was assessed by quantitative RT-PCR in fresh CRC samples and 
corresponding tumor-free tissues. Chemokine receptor expression on TILs was evaluated by 
flow cytometry on cell suspensions from digested tissues. Chemokine production by CRC 
cells was evaluated in vitro and in vivo, upon generation of intraperitoneal or intracecal tumor 
xenografts in immune-deficient mice. T cell trafficking was assessed upon adoptive transfer 
of human TILs into tumor-bearing mice. Gut flora composition was analyzed by 16srRNA 
sequencing. 
Results: CRC infiltration by distinct T cell subsets was associated with defined chemokine 
gene signatures, including CCL5, CXCL9, and CXCL10 for cytotoxic T lymphocytes and T-
helper (Th)1 cells, CCL17, CCL22, and CXCL12 for Th1 and regulatory T cells, CXCL13 for 
follicular Th cells, and CCL20 and CCL17 for IL-17-producing Th cells. These chemokines 
were expressed by tumor cells upon exposure to gut bacteria in vitro and in vivo. Their 
expression was significantly higher in intracecal than in intraperitoneal xenografts and was 
dramatically reduced by antibiotic treatment of tumor-bearing mice. In clinical samples, 
abundance of defined bacteria correlated with high chemokine expression, enhanced T cell 
infiltration and improved survival.  
Conclusions: Gut microbiota stimulate chemokine production by CRC cells, thus favoring 
recruitment of beneficial T cells into tumor tissues.  
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Significance of this study 
What is already known about this subject?  
➢ Infiltration of human colorectal cancers (CRC) by cytotoxic T lymphocytes (CTLs), 
T-helper 1(Th1), Foxp3+ regulatory T cells (Tregs), and CXCR5+ follicular T-helper 
cells (Tfh) predicts prolonged survival. In contrast, the prognostic relevance of IL-17-
producing T-helper cells (Th17) is still controversial. Chemotactic factors recruiting 
these immune cell types into tumor tissues have not been fully investigated yet. 
 
➢ High expression of CXCL9, CXCL10, CXCL16, and CX3CL1 genes, correlates with 
more favorable clinical outcome, but mechanisms underlying their positive prognostic 
significance remain to be elucidated. 
 
➢ In CRC gut microbiota translocate across the neoplastic epithelium, but whether this 
phenomenon may impact on the production of chemokines recruiting immune cells 
has not been assessed so far.  
 
What are the new findings? 
➢ CRC infiltration by favorable immune cell populations is associated with expression 
of defined chemokine genes, i.e. mainly CCL5, CXCL9 and CXCL10 for CTLs and 
Th1, CCL17, CCL22, and CXCL12 for Th1 and Tregs, CXCL13 for Tfh, and CCL20 
and CCL17 for Th17.  
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➢ Most chemokine genes identified may be expressed by CRC cells in response to 
stimulation with gut microbiota-derived stimuli. 
 
➢ In tumor xenografts, bacterial loads correlate with chemokine gene expression levels 
and extent of T cell infiltration.  
 
➢ In clinical CRC samples abundance of defined bacteria families correlates with 
expression of specific chemokine genes, extent of T cell infiltration and improved 
prognosis.  
 
How might it impact on clinical practice in the foreseeable future? 
➢ Our findings reveal the ability of gut microbiota to induce in CRC cells the production 
of chemotactic factors recruiting T cell populations of favorable prognostic 
significance. This knowledge might pave the way toward the development of 
innovative treatments aimed at modifying the gut flora to promote CRC infiltration by 
beneficial immune cells. 
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Introduction 
Infiltration by immune cells heavily impacts on clinical outcome in human colorectal cancer 
(CRC) (1). High densities of cytotoxic CD8+ T cells (2;3), IFN-g expressing T-helper 1 cells 
(Th1)(4), CXCR5+ follicular T-helper cells (Tfh) (5) and, surprisingly, Foxp3+ regulatory T 
cells (Tregs) (6;7) are associated with prolonged patients’ survival. Consistent with positive 
role of T-helper cells, expression of HLA class II antigens was also reportedly associated with 
favorable clinical course (8). In contrast, prognostic significance of IL-17 producing T-helper 
cells (Th17) is controversial: their presence within CRC tissues was reported to correlate 
either with poor (4) or improved prognosis (9). In addition, innate immune cells were also 
shown to predict clinical outcome. Tumor infiltration by CD16+ myeloperoxidase (MPO)+ 
myeloid cells, mostly consisting of activated neutrophils, is an independent predictor of 
favorable prognosis (10-12). Notably, infiltration by neutrophils or natural killer (NK) cells 
was also found to increase favorable prognostic significance of cytotoxic CD8+ T cells 
(11;13). 
Chemotactic factors driving these cell populations into CRC tissues remain largely undefined. 
Expression of defined chemokines, including CXCL9 (14), CXCL10 (14), CXCL16 (15), and 
CX3CL1 (5), was reported to correlate with high densities of tumor infiltrating lymphocytes 
(TILs), and to predict favorable clinical outcome. However, putative responding cell subsets 
within immune infiltrating cells have not been carefully characterized. Furthermore, 
chemokine sources and micro-environmental stimuli leading to chemokine production within 
CRC tissues were not addressed so far.  
Upon intestinal tumorigenesis gut commensal bacteria translocate across altered epithelia and 
stimulate immune cells infiltrating lamina propria to release pro-inflammatory cytokines (16). 
However, whether gut flora-derived microbial stimuli also promote production of chemotactic 
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factors was not evaluated yet. Here we investigated chemokine-chemokine receptor network 
underlying T cell infiltration into CRCs.  
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Materials and methods 
Clinical specimen collection and processing  
Clinical specimens were collected from consenting patients undergoing surgical treatment at 
Basel University Hospital, St. Claraspital in Basel, and Ospedale Civico di Lugano, 
Switzerland (Swiss cohort, n=62), and at Klinikum Rechts Der Isar, Münich, Germany 
(German cohort, n=31). Use of human samples was approved by local ethical authorities 
(Ethikkommission Nordwest und Zentralschweiz, Comitato etico cantonale Ticino, and Ethics 
committee of the Faculty of Medicine of the TUM). Clinical-pathological characteristics of 
patients included in these cohorts are reported in Table S1. For details on sample processing 
and analysis by flow cytometry see “Supplementary Methods” and Table S2.  
 
CRC cell stimulation with Toll-like receptor (TLR) agonists and bacteria  
Cells from established cell lines or CRC-derived organoids were incubated with indicated 
concentrations of TLR agonists or heat-inactivated bacteria (bacteria: tumor cell ratio = 30:1) 
at 37 C. After 4 hours, chemokine expression was assessed by qRT-PCR. Details regarding 
cell lines, organoids, bacteria cultures, TLR agonists, and qRT-PCR are provided in 
Supplementary Methods and Table S3.  
 
In vivo experiments 
In vivo experiments were approved by Basel and Zürich Cantonal Veterinary offices. 
Tumor xenografts were generated in eight-week old NSG mice (NOD.Cg-Prkdcscid 
Il2rgtm1Wjl/SzJ,) upon intra peritoneum (i.p.) and intra cecum (i.c.) injection (17) of LS180 
cells. 
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(see “Supplementary Methods” for full details). From day 10, a randomized group of i.c. 
injected mice was treated with Ampicillin sodium salt (1 g/L, Amresco) and Vancomycin 
Hydrochloride (0.2 g/L, Bio Basic Canada), administered in drinking water.  Tumors were 
harvested on day 31 and assessed for chemokine gene expression.  
To evaluate T cell migration, at day 29 tumor bearing mice were adoptively transferred with 
CFSE-labeled CD4+ and CD8+ T cells, previously isolated from primary CRC specimens and 
expanded in vitro (5×106 T cells/subset/mouse). Two days later, frequencies of transferred 
TILs were evaluated in cell suspensions of digested tumors by flow-cytometry.  
Details of mice, tumor cell injection protocols, and TIL isolation are provided in 
“Supplementary Methods”. 
 
16SrRNA gene sequencing and analysis 
Bacterial flora was analyzed based on 16S rRNA sequencing. Total RNA was purified from 
27 CRC tissue samples (German cohort) and reverse transcribed. V4 region of the bacterial 
16SrRNA gene was amplified by PCR. Amplicons were sequenced on the Illumina MiSeq 
platform. Sequences were analyzed by USEARCH software (v8.1.1861). Differential 
operational taxonomic unit (OTU) analysis of normalized abundance counts was performed 
by DESeq2 software (v1.12.4). Libraries, sequencing and data analysis were performed by 
Microsynth AG (Balgach, Switzerland) as detailed in “Supplementary Methods”. 
 
Statistical analysis 
Methods used to evaluate statistical significance of results are detailed in Figure legends.  
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Results 
CRC infiltration by T cells is associated with overexpression of defined chemokines. 
We analyzed expression of genes encoding immune cell markers, including CD3 for total T 
cells, CD4 for T-helper cells, CD8 for CTLs, T-bet and IRF-1 for Th1, IL-4, IL-5 and IL-13 
for Th2, IL-17 for Th17, CXCR5 for Tfh, and Foxp3 for Tregs, in 62 CRC and corresponding 
tumor-free colonic tissues (Figure 1A). All T cell markers were expressed, except for IL-4 
which was undetectable in all samples (data not shown), and IL-5 and IL-13, expressed only 
in a few samples, thus suggesting that CRC infiltration by Th2 cells in CRC is marginal.  IL-
17 and Foxp3 gene expression was significantly increased in tumors as compared to control 
tissues (p<0.0001), whereas expression of CD4 and CXCR5 genes was slightly reduced 
(p<0.05). Expression of all T cell subset markers, except IL-17, significantly correlated with 
that of CD3 and CD4. Furthermore, CD8, IRF-1 and CXCR5, were significantly associated 
with expression of T-bet and Foxp3 (Table S4).  
Normalization of immune cell marker expression in tumor samples versus corresponding 
tumor-free colonic tissues revealed a consistent subgroup of samples displaying upregulation 
of one or more T cell markers (Figure S1). Upon unsupervised hierarchical analysis, samples 
clustered in three main groups: one characterized by overexpression of most T cell markers 
(cluster “high”), a second displaying heterogeneous expression (cluster “het”), and a third 
characterized by downregulation of all T cell marker genes (cluster “low”, Figure 1B). 
Analysis of different clusters revealed a panel of chemokine genes significantly upregulated 
in highly but not in poorly infiltrated tumors (Figure 1C). Furthermore, significant 
correlations between expression of genes encoding individual chemokines and specific 
immune cell markers were observed (Table 1), suggesting that these chemokines might be 
involved in T cell recruitment into tumor tissues.  
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TILs express receptors binding overexpressed chemokines 
We then analyzed chemokine receptor profiles of CD8+, CD4+ (Foxp3-) effector T cells, and 
CD4+ Foxp3+ Tregs, in freshly excised CRC specimens as compared to control tissues or 
PBMCs from patients or HDs (Figure 2 and Figure S2). All three subsets in tumors and 
control tissues were largely positive for CCR5, CXCR3, and CXCR4, whereas lower cell 
fractions expressed CCR3, CCR6 and CCR10. Remarkably, significantly higher percentages 
of CCR5+ and CXCR4+ T cells were detected in tissues as compared to PBMCs (Figure S2).  
Considerable fractions of CD4+ T cells and Tregs also expressed CCR4. Furthermore, within 
CD4+ T cells a small subset of CXCR5+ cells was detectable, confirming tumor infiltration 
by Tfh. This cell subset, however, did not show significant expression of additional 
chemokine receptors. Chemokine receptor profiles on Th1 and Th17 cells could not be 
properly assessed, since the stimulation, required for their identification, based on cytokine 
production capacity, causes down-modulation of most chemokine receptors (data not shown). 
We could only detect CCR6 on a large majority of Th17 cells (up to 88%), as previously 
reported (9), and CCR4 on a smaller fraction (up to 38%). 
Expression of CCR1 or CCR11 was undetectable in all T cell subsets (data not shown). No 
major differences in chemokine receptor profiles were observed between PBMCs of patients 
and healthy donors (Figure S2). 
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Table 1. Correlations between expression of genes encoding chemokines and immune cell markers in CRC specimens (n=62) * 
 CD8 T-bet IRF1 IL-17 CXCR5 Foxp3 
 Spearman r P value Spearman r P value Spearman r P value Spearman r P value Spearman r P value Spearman r P value 
CCL2 0.3960 0.0020 0.4100 0.0010 0.4250 0.0010 0.0060 0.9660 0.1880 0.1470 0.4620 <0.0001 
CCL3 0.4036 0.0015 0.1247 0.3468 0.3205 0.0133 -0.2230 0.0890 -0.0560 0.6730 0.1519 0.2509 
CCL4 0.3454 0.0069 0.0162 0.9021 0.0687 0.6017 -0.0700 0.5960 -0.0440 0.7370 -0.0533 0.6857 
CCL5 0.6544 <0.0001 0.4252 0.0007 0.5578 <0.0001 -0.0300 0.8180 0.2750 0.0330 0.3399 0.0079 
CCL7 0.3258 0.0104 0.0736 0.5730 0.2613 0.0420 -0.0010 0.9930 -0.0230 0.8600 0.1244 0.3396 
CCL8 0.4632 0.0002 0.1333 0.3056 0.2969 0.0202 -0.0720 0.5820 0.0880 0.5000 0.2038 0.1152 
CCL11 0.3410 0.0080 0.3620 0.0040 0.4680 <0.0001 0.0620 0.6370 0.1560 0.2330 0.5540 <0.0001 
CCL13 0.4097 0.0010 0.1364 0.2944 0.3265 0.0102 -0.0240 0.8520 0.2040 0.1150 0.1764 0.1739 
CCL14-15 0.0230 0.8610 0.1020 0.5340 -0.0310 0.8110 0.3460 0.0060 -0.1950 0.1330 -0.0820 0.5280 
CCL17 0.3234 0.0110 0.1834 0.1571 0.4450 0.0003 0.3000 0.0190 0.2310 0.0740 0.2646 0.0393 
CCL18 0.2420 0.0610 0.3500 0.0060 0.3110 0.0150 -0.0710 0.5870 0.2090 0.1060 0.2310 0.0730 
CCL19 0.5270 0.0010 0.5900 <0.0001 0.5270 <0.0001 0.0020 0.9880 0.5380 <0.0001 0.4890 0.0001 
CCL20 -0.2528 0.0493 -0.2051 0.1128 -0.0933 0.4743 0.4440 0.0003 -0.1510 0.2450 -0.1297 0.3192 
CCL21 0.4070 0.0010 0.5560 <0.0001 0.4770 <0.0001 -0.1890 0.1450 0.1970 0.1270 0.5900 <0.0001 
CCL22 0.3754 0.0029 0.4432 0.0003 0.6803 <0.0001 0.1570 0.2280 0.3550 0.0050 0.7033 <0.0001 
CCL23 0.3510 0.0050 0.1270 0.3280 0.3410 0.0070 -0.0940 0.4720 0.1120 0.3920 0.1640 0.2070 
CCL24 -0.1050 0.1230 0.1350 0.3010 0.2620 0.0410 0.0540 0.6780 -0.0560 0.6660 0.0660 0.6160 
CCL25 0.2174 0.0923 0.2541 0.0482 0.1778 0.1703 0.3830 0.0020 0.1580 0.2240 0.2226 0.0847 
CCL26 0.1350 0.3010 0.2190 0.0890 0.3010 0.0180 0.0450 0.7280 0.2170 0.0930 0.1780 0.1700 
CCL27 0.0110 0.2460 0.0410 0.7530 0.0110 0.9310 0.4180 0.0010 0.1630 0.2110 0.1120 0.3900 
CCL28 -0.0320 0.3930 0.0110 0.9310 -0.0320 0.8070 0.3570 0.0050 -0.0450 0.7280 -0.1290 0.3200 
CXCL3 -0.1850 0.1250 -0.0330 0.8000 -0.1850 0.1540 0.3790 0.0030 0.0420 0.7490 -0.2030 0.1170 
CXCL9 0.5509 <0.0001 0.4138 0.0010 0.5125 <0.0001 0.1590 0.2260 0.3910 0.0020 0.3458 0.0068 
CXCL10 0.4268 0.0006 0.2867 0.0251 0.1835 0.1569 0.1670 0.1970 0.2560 0.0460 0.1431 0.2711 
CXCL11 0.2075 0.1085 0.2361 0.0669 0.3708 0.0033 0.1200 0.3570 0.2060 0.1110 0.1436 0.2697 
CXCL12 0.5330 <0.0001 0.3592 0.0045 0.5795 <0.0001 -0.2650 0.0390 0.2060 0.1120 0.4887 0.0001 
CXCL13 0.4810 0.0001 0.6110 <0.0001 0.4270 0.0010 0.1110 0.3920 0.5760 <0.0001 0.5090 <0.0001 
CXCL14 0.0800 0.5610 0.0810 0.5550 0.4150 0.0020 0.2130 0.1180 0.1360 0.3240 0.2740 0.0430 
CXCL16 0.2864 0.0252 0.1562 0.2293 0.4231 0.0007 0.0040 0.9740 0.0860 0.5110 0.2046 0.1138 
CX3CL1 0.2703 0.0351 0.3134 0.0139 0.5272 <0.0001 -0.2010 0.1200 0.0190 0.8870 0.4085 0.0011 
*Significant correlation coefficients ≥0.3 are indicated in bold 
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Defined chemokine signatures underlie CRC infiltration by individual T cell subsets  
Chemokines significantly correlating with any T cell marker were assigned scores, calculated 
according to the formula (Spearman r value x percentage of corresponding chemokine 
receptor-positive cells) (Table S5). Thus, we identified putative chemokine signatures for 
each T cell subset (Figure 3). In particular, for CTLs we identified CCL3, CCL4, CCL5, and 
CCL8 (binding to CCR5), CXCL9 and CXCL10 (binding to CXCR3), and CXCL12 (binding 
to CXCR4). Th1-associated chemokine signature mainly included CCR4-ligands CCL17 and 
CCL22, together with CCL3, CCL5, CXCL9, CXCL11, CXCL12, CCL17 and CCL22, and to 
a lower extent CCL5 and CXCL9,  also underlay tumor infiltration by Tregs. Infiltration by 
Tfh was exclusively associated with expression of CXCL13, whereas Th17-associated 
signature included CCL20 and CCL17, and to a lower extent CCL25, CCL27, and CCL28. 
Identified signatures were validated in a larger cohort, including 311 CRC samples from The 
Cancer Genome Atlas (TCGA, cancergenome.nih.gov) (Figure S3). Unsupervised 
hierarchical analysis identified different clusters. One (indicated in red) included samples  
overexpressing CD8, IRF-1/T-bet, FoxP3, and CXCR5, and all corresponding chemokines; a 
second one (blue) grouped samples showing low expression of all markers and related 
chemokines. Consistent with observations in our cohort, expression of IL-17 and Th-17 
related chemokines clustered separately from other T cell markers and chemokines (cluster 
orange). Two remaining clusters (indicated in green) showed heterogeneous expression of all 
markers and chemokines (Figure S3A).  Importantly, samples overexpressing all T cell 
markers (except IL-17) and their chemokine signatures showed improved survival as 
compared to those from other clusters (Figure S3B). Thus, overexpression of the identified 
chemokines associates with infiltration by beneficial T cell populations and improved 
prognosis. 
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T cell recruiting chemokines are expressed by tumor cells 
To identify cellular sources of T cell recruiting chemokines, we evaluated their potential 
production by tumor cells, the major component of CRC microenvironment. Gene expression 
analysis of chemokines in primary CRC cells, isolated from freshly excised CRC specimens 
based on EpCAM expression, revealed that tumor cells express most relevant chemokine 
genes (Figure 4). For some chemokines, including CCL3, CCL4, and CCL20, gene 
expression levels were significantly higher in purified CRC cells than in total tumor tissues, 
suggesting that tumor cells are likely major contributors of these chemokines within CRC 
microenvironment. In contrast, purified tumor cells did not express CCL7, CCL8, CCL11, 
CCL13, CCL17, and CCL27 genes (data not shown). 
Remarkably, in vitro cultured CRC cell lines expressed fewer chemokine genes and to lower 
extents as compared to primary tumor cells, suggesting that chemokine expression in tumor 
cells may be stimulated by microenvironmental factors absent in vitro.   
 
Chemokine expression is induced in CRC cells by gut-flora derived stimuli 
Translocation of commensal bacteria or derived stimuli across altered epithelia was described 
in CRC (16). We hypothesized that chemokine production in tumor cells may be triggered by 
gut flora-derived microbial stimuli. Indeed, CRC cells from primary tumors and established 
cell lines express TLRs potentially sensing them (Figure S4). Stimulation of CRC cells from 
cell lines (Figure 5A and Figure S5) and CRC organoids (Figure S6) with TLR agonists 
induced upregulation of constitutively expressed chemokine genes, including CCL20, 
CXCL9, and CXCL10, and de novo expression of additional chemokine genes, including 
CCL3, CCL4, CCL5 and CCL22. In contrast, no CXCL12 expression was observed.   
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Upregulation of most chemokine genes was also induced upon exposure of CRC cells to 
bacterial species enriched in CRC tissues, including Fusobacterium nucleatum, Bacteroides 
fragilis, and Escherichia coli (18-20) (Figure 5B and Figure S6). Thus, microbial stimulation 
appears to be sufficient to partially recapitulate in cell lines chemokine expression profiles of 
primary CRC.  
We further investigated effects of gut commensal bacteria on chemokine expression in vivo. 
Levels of chemokine expression were evaluated in tumor xenografts generated in NSG mice 
upon i.p. or i.c. injection of human CRC cells from established cell lines. Strikingly, 
intracecal tumors displayed significantly higher levels of CCL5 (70-fold increase), CCL20 
(19-fold increase), CXCL10 (12-fold increase) and CXCL11 (3-fold increase), as compared to 
i.p. xenografts (Figure 6A), suggesting that chemokine expression is strongly induced by 
exposure to gut flora. Importantly, antibiotic treatment of tumor bearing mice dramatically 
reduced tumor-derived chemokine expression in i.c. xenografts (Figure 6A), indicating that 
commensal bacteria are main chemokine inducers in CRC cells. Indeed, expression levels of 
CCL20, CXCL10 and CXCL11 in xenografts significantly correlated with bacterial loads, as 
assessed by ribosomal subunit 16S expression (Figure S7A). Furthermore, gut flora 
composition analysis revealed a reduction of specific bacteria families within Bacteroidetes 
and Firmicutes in xenografts from antibiotic-treated versus untreated mice (Figure S7B, C and 
Table S6). Moreover, significant correlations between abundance of Rikenellaceae, 
Ruminococcace, and Lachnospiracee and expression levels of CCL5, CCL20, and CXCL11 
were detected (Figure S7D and Table S7). 
 
Gut microbiota in tumors correlate with extent of T cell infiltration 
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To assess actual impact of bacteria-induced chemokines on T cell recruitment into tumor 
tissues, we adoptively transferred CRC-derived CD4+ and CD8+ TILs into tumor bearing 
NSG mice and evaluated their homing to i.p. or i.c. tumors. Strikingly, TILs migrated into i.c. 
xenografts to significantly higher extents than in i.p. tumors (Figure 6B, C), indicating that 
presence of gut microbiota enhances T cell recruitment into xenografts.  
Consistently, in human CRC samples displaying high densities of CD3+ cells, gut bacteria, as 
detected by FISH analysis, appeared more abundant than in poorly infiltrated tumors (Figure 
S8A).  However, only weak to moderate correlations were observed between 16S and IRF-1 
(r=0.267;p=0.034), CCL3 ( r=0.457; p=0.0019), and CXCL12 (r=0.348;p=0.005), suggesting 
that specific bacteria families, rather than total bacterial loads,  influence T cell recruitment 
into CRC tissues. We therefore analyzed gut flora composition of CRC samples previously 
characterized for abundance of CD3+ infiltrates (German cohort, n=27) and corresponding 
tumor-free tissues. Overall, the majority of detectable bacteria were represented by 
Bacteroidetes, Proteobacteria, and Firmicutes, as previously reported (19) (Figure S8B). In 
line with previous studies (18;19), Bacteroidetes and Firmicutes were slightly reduced in 
tumor tissues as compared to corresponding tumor-free tissues, whereas Fusobacteria were 
significantly increased (p=0.014, Figure S8B). Unsupervised hierarchical analysis of 
operational taxonomic unit (OTU) abundances in tumor tissues, identified two main clusters 
one (indicated in orange) including 10/13 samples displaying low CD3 densities (CD3low), 
and a second (green) including all 14 tumors displaying high CD3 densities (CD3high) plus 3 
CD3low tumors (Figure 7A). Importantly, samples from the green cluster displayed a 
significantly prolonged survival as compared to orange cluster samples (Figure 7B). Specific 
bacteria genera, including Alloprevotella, Treponema, and Desulfovibrio, were significantly 
enriched in CD3high tumors, whereas, Prevotella, Bacteroides, and Fretibacterium, among 
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others, were overrepresented in CD3low tumors (Figure 7B and Table S8). Expression of T 
cells markers and chemokine genes was also assessed in these samples. Consistent with 
results from previous cohort, CD8, IRF-1, Foxp3 and CXCR5 were strongly associated with 
each other and with previously identified chemokine signatures (Figure 8A and Table S9). 
Unfortunately, correlations with IL-17 were not evaluable since this cytokine was poorly 
expressed in these samples. Most importantly, significant correlations between abundance of 
specific bacteria and expression of individual T cell markers and chemokines genes were 
observed. In particular, abundance of different families of Firmicutes, mainly including 
Lachnospiraceae and Ruminococcaceae, significantly correlated with expression of CCR5 and 
CXCR3 binding chemokines. Abundance of Proteobacteria, and, in particular, 
Methylobacteriaceae, was also associated with expression of all prognostically favorable T 
cell markers and most corresponding recruiting chemokines (Figure 8B and Table S10). Thus, 
expression of chemokine genes in human CRC tissues is associated with abundance of 
specific bacteria.   
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Discussion 
Aim of this study was to elucidate the nature of chemotactic factors promoting infiltration of 
human CRC by T cell populations associated with favorable prognosis, and to gain insights 
on cellular sources and stimuli eliciting their production within CRC microenvironment.   
Based on correlations between expression of T cell markers and chemokines in freshly 
excised CRC tissues, and on chemokine receptor profiles of tumor infiltrating immune cells, 
we identified prominent chemokine signatures associated with recruitment of individual 
immune cell populations into CRC tissues. In particular, expression of CCR3- and CCR5-
binding chemokines, including CCL3, CCL4, CCL5, CCL7, CCL8, and CCL13, and of 
CXCR3 ligands, including CXCL9 and CXCL10, correlated with presence of both CTLs and 
Th1 cells. This may suggest that these subsets, expressing similar chemokine receptor 
patterns, may be concomitantly recruited. Indeed, in our sample cohort, a significant positive 
correlation between expression of CD8 and IRF-1 was detected. 
More surprisingly, Th1- and, to a lower extent, CTL-related signatures also partially 
overlapped with that underlying Tregs infiltration. Remarkably, both Th1 and Tregs markers 
were associated with expression of CXCL12, and of CCR4-ligands CCL17 and CCL22. Also, 
a weak but significant correlation was detected between Tregs infiltration and expression of 
CCL5 and CXCL9. Although unexpected, these findings are consistent with chemokine 
receptor profiles displayed by Tregs, largely resembling those of Th1, and, to lower extents, 
of CTLs. Thus, within CRC tissues, recruitment of Tregs may parallel that of effector T cells. 
Accordingly, Foxp3 expression in CRC samples significantly correlated with that of both 
CD8 and IRF-1 genes.  
In contrast, chemokine signatures associated with infiltration by Tfh and Th17 were clearly 
distinct, the first being exclusively represented by CXCL13, and the second by CCL20 and 
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CCL17, and to lower extents CCL25, CCL27, and CCL28. Unexpectedly, however, in both 
cohorts analyzed, expression of CXCR5 and CXCL13 clustered with that of CD8, IRF-1, 
Foxp3 and correlating chemokines, suggesting that infiltration by Tfh cells may also parallel 
that of CTLs, Th1 and Tregs. Thus, expression of CXCL13, by primary CRC cells, could be 
evoked by stimuli also inducing secretion of CTL, Th1 and Tregs recruiting chemokines (see 
below).  
Overexpression of defined chemokines in CRC tissues, particularly CCL5, CXCL9 and 
CXCL10, was previously reported to be associated with improved patient survival (14). 
However, specific cell populations recruited by these chemokines were not investigated.  Our 
study demonstrates that receptors binding these chemokines, i.e. CCR5 and CXCR3, are 
widely expressed by different subsets of TILs, including CTLs Th1, and Tregs, predictive of 
favorable clinical outcome. Therefore, positive prognostic significance of these chemokines 
might rely on their capacity to attract beneficial T cell populations within tumors. Due to the 
prospective nature of our study, we could not assess in our cohort the impact on identified 
chemokines on patient’s survival, usually evaluated after 5 years. However, analysis of a 
public database including transcriptomic and clinical data confirmed the associations between 
expression of identified T cell markers and chemokines, and their link with improved clinical 
outcome.  
Our work identifies tumor cells as important chemokine sources. CRC cells per se express a 
spectrum of chemokines relevant for the recruitment of favorable immune cells, including 
CCL3, CCL4, CCL5, CCL20, and CXCL10, binding receptors expressed by CTLs and Th1 
cells. In contrast, genes encoding chemokines involved in recruitment of Tregs, including 
CCL17 and CCL22, although detected in CRC tissues, were rarely expressed by purified CRC 
cells, suggesting that they may be mainly produced by other cell types within tumor 
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microenvironment. Notably, in a melanoma model, Tregs recruiting chemokines were 
secreted by tumor infiltrating CTLs (21). In our sample cohort, a significant correlation 
between expression of CD8 and CCL17 and CCL22 genes was observed, possibly suggesting 
that also in CRC they might derive from CTLs.   
Remarkably, CRC cells isolated from different samples displayed heterogeneous chemokine 
gene expression levels, possibly reflecting distinct molecular characteristics and/or exposure 
to different microenvironmental conditions. Genomic alterations occurring in CRC cells were 
reported to result in loss or amplification of chemokine genes (5). More recently, epigenetic 
silencing of Th1-type chemokines in CRC was also described (22). Thus, differential genomic 
and epigenomic instability may at least partially explain heterogeneity of chemokine gene 
expression across different samples. Accordingly, different CRC cell lines, although 
maintained under comparable culture conditions, displayed variable degrees of chemokine 
production capacity.  
Importantly, in vitro cultured cell lines generally display significantly lower chemokine gene 
expression levels than primary CRC cells, indicating that micro-environmental stimuli also 
play relevant roles in modulating chemokine gene expression.  Previous studies showed that 
gut commensal bacteria translocated across the neoplastic epithelium may interact with tumor 
cells and induce direct pro-tumorigenic effects (23;24) or release of pro-tumorigenic 
cytokines (16). However, their potential modulation of chemokine production by tumor cells 
was not evaluated so far. Strikingly, we found that stimulation by gut commensal bacteria in 
vitro and in vivo induces in tumor cell lines upregulation or de novo expression of multiple 
chemokine genes, recapitulating profiles and levels of chemokine gene expression of primary 
CRC cells. Most interestingly, we demonstrated that tumor cell exposure to gut bacteria 
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ultimately results in higher T cell recruitment into tumor xenografts, revealing a role of gut 
commensal bacteria in controlling extent of tumor infiltration by beneficial immune cells.   
Consistent with in vivo findings, we found that extent of T cell infiltration in primary human 
CRCs is significantly associated with presence of specific bacteria families and genera. 
Furthermore, we observed significant correlations between abundance of defined bacteria 
families and expression levels of specific chemokine genes, indicating that gut commensal 
bacteria trigger production of immune cell recruiting chemokines within tumor tissues. 
Importantly, composition of gut flora also predicted improved survival. Notably, the cluster 
associated to more favorable prognosis also included three samples displaying low T cell 
infiltration, possibly suggesting that certain bacteria may favor recruitment of immune cells 
other than T cells, also beneficially impacting on clinical outcome, including neutrophils 
(10;11) and NK cells (13). Although additional studies are warranted to elucidate potential 
interactions between gut microbiota and additional immune cell populations, it is tempting to 
speculate that gut flora composition in CRC patients may concur with tumor genetic 
characteristics to determine extent and quality of immune cell infiltration, determining clinical 
outcome.  
Specific bacterial species or strains mostly contributing to high chemokine expression and 
immune cell infiltration in human CRC samples remain to be identified.  In in vitro 
experiments we found that different species of CRC-associated bacteria, including 
Escherichia coli and Bacteroides fragilis, may promote, although to different extents, 
expression of T cell recruiting chemokine genes. Ex-vivo analysis of human samples showed 
that Firmicutes, and in particular Lachnospiraceae and Ruminococcaceae, although 
represented in gut flora to lower extents than other phyla, are mostly associated with 
expression of T cell recruiting chemokines. Furthermore, abundance of Bacteroides and 
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Proteobacteria also correlated with expression of most T cell recruiting chemokines and with 
tumor infiltration by all T cell subsets predictive of good prognosis. Notably, defined bacteria 
types were associated with expression of multiple chemokine encoding genes, possibly 
indicating their capacity to promote simultaneous recruitment of different T cell populations. 
This is consistent with the clustering of the expression of CD8, Th1, Foxp3 and CXCR5 
observed in clinical samples, characterized by favorable prognosis. 
Surprisingly, also bacterial species, such as Fusobacteria, reportedly associated with severe 
clinical outcome (25), and that we found enriched in poorly infiltrated tumors, were capable 
to evoke expression of T cell recruiting chemokine genes by CRC cells in vitro. Further 
studies are warranted to clarify the final impact of individual bacterial species, and 
Fusobacteria in particular, on T cell function. It is conceivable that some bacteria might attract 
immune cells into tissues while inhibiting their functions. For instance, Fusobacterium 
nucleatum has been reported to inhibit T and NK cell functions via TIGIT (26). Also, defined 
bacterial strains may play multifaceted functions differentially impacting on clinical outcome. 
In this line, a recent study has described an association between abundance of Fusobacteria 
species and high expression of IL-12 and TGF-β, ultimately promoting differentiation of a T 
cell subset characterized by low Foxp3 expression and predictive of favorable survival (27).  
Molecular mechanisms mediating the cross-talk between CRC cells and gut bacteria also 
remain to be elucidated. Colon epithelial cells are capable of sensing gut microorganism 
through pattern recognition receptors (PRRs), including TLRs (28). Our data suggest that 
bacteria-induced chemokine gene expression may be initiated upon TLR triggering on tumor 
cells. Indeed, we observed TLRs expression on primary CRC cells. Furthermore, stimulation 
with purified TLR agonists resulted in marked induction of chemokine gene expression in 
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CRC cells. However, further studies are warranted to precisely identify which TLRs, and, 
possibly, other PRRs, are engaged by individual CRC associated bacterial species.  
In conclusion, our study identifies tumor cells as a major chemokine source in CRC and 
reveals the key role played by gut microbiota in triggering chemokine production ultimately 
leading to T cell recruitment in tumor tissues and improved prognosis. This knowledge might 
eventually pave the way toward development of innovative treatments aimed at modifying gut 
flora to promote CRC infiltration by immune cell populations of favorable prognostic 
significance.  
  
24 
 
Acknowledgments  
We thank Anne-Kathrin Woischnig and Dr. Matthias Schmaler for their precious advices and 
help with bacteria cell cultures, Dr. Robert Ivanek and Dr. Pascal Weigold for data analysis, 
and Dr. Petra Makovac for helping with clinical data management. We are grateful to Dr. 
Elisabetta Padovan, Dr. Anna Marsano, Dr. Christoph Grünig, Prof. Roxane Tussiwand, and 
Prof. Benjamin Marsland, for critical comments and discussion, and to Prof. Michael Heberer 
for his support throughout the development of the project. 
 
Contributors: G.I. conceived and designed experiments, analyzed and interpreted results, 
obtained funding, wrote the manuscript; E.C. designed and performed experiments, analyzed 
and interpreted results, wrote the manuscript; F.A., J.F.G.G., V.G., M.G.M., V.M., V.G.F., 
S.K., J.S.H., L.M.T., contributed to design and conduction of experiments, and to analysis and 
interpretation of data; D.O., S.D., M.B., R.R., B.W., and U.N. contributed to conception of 
research and data collection; G.C. S., N.K., A.E., P.Z., S.E.C, K.P.J., and L.B. contributed to 
conception of research, design and conduction of experiments, analysis and interpretation of 
data, and writing of the manuscript. 
 
Funding: Swiss National Science Foundation (SNF PP00P3-133699 and PP00P3-159262), 
University of Basel (Unibas Förderung des Akademischen Mittelbaus) and Department of 
Surgery, Basel University Hospital.  
Patient consent: Obtained 
Ethics approval: EKBB/EKNZ (study protocol n. 2014-388), Ethics Committee of the 
Faculty of Medicine of the TUM (#1926/2007), Cantonal Veterinary Office Basel-Stadt 
(license n. 2266), Cantonal Veterinary Office Zürich (license n. 35/2014). 
25 
 
Competing interests: The authors have no conflicts of interest to disclose. 
 
References 
 
 (1)  Fridman WH, Pages F, Sautes-Fridman C et al. The immune contexture in human 
tumours: impact on clinical outcome. Nat Rev Cancer 2012;12(4):298-306. 
 (2)  Galon J, Costes A, Sanchez-Cabo F et al. Type, density, and location of immune cells 
within human colorectal tumors predict clinical outcome. Science 
2006;313(5795):1960-4. 
 (3)  Pages F, Berger A, Camus M et al. Effector memory T cells, early metastasis, and 
survival in colorectal cancer. N Engl J Med 2005;353(25):2654-66. 
 (4)  Tosolini M, Kirilovsky A, Mlecnik B et al. Clinical impact of different classes of 
infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with 
colorectal cancer. Cancer Res 2011;71(4):1263-71. 
 (5)  Bindea G, Mlecnik B, Tosolini M et al. Spatiotemporal dynamics of intratumoral 
immune cells reveal the immune landscape in human cancer. Immunity 
2013;39(4):782-95. 
 (6)  Frey DM, Droese RA, Viehl CT et al. High frequency of tumor-infiltrating FOXP3+ 
regulatory T cells predicts improved survival in mismatch repair-proficient colorectal 
cancer patients. Int J Cancer 2009. 
 (7)  Salama P, Phillips M, Grieu F et al. Tumor-infiltrating FOXP3+ T regulatory cells 
show strong prognostic significance in colorectal cancer. J Clin Oncol 
2009;27(2):186-92. 
 (8)  Sconocchia G, Eppenberger-Castori S, Zlobec I et al. HLA class II antigen expression 
in colorectal carcinoma tumors as a favorable prognostic marker. Neoplasia 
2014;16(1):31-42. 
 (9)  Amicarella F, Muraro MG, Hirt C et al. Dual role of tumour-infiltrating T helper 17 
cells in human colorectal cancer. Gut 2017;66(4):692-704. 
 (10)  Droeser RA, Hirt C, Eppenberger-Castori S et al. High myeloperoxidase positive cell 
infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS 
One 2013;8(5):e64814. 
 (11)  Governa V, Trella E, Mele V et al. The Interplay Between Neutrophils and CD8+ T 
Cells Improves Survival in Human Colorectal Cancer. Clin Cancer Res 2017. 
26 
 
 (12)  Sconocchia G, Zlobec I, Lugli A et al. Tumor infiltration by FcgammaRIII (CD16)+ 
myeloid cells is associated with improved survival in patients with colorectal 
carcinoma. Int J Cancer 2011;128(11):2663-72. 
 (13)  Sconocchia G, Eppenberger S, Spagnoli GC et al. NK cells and T cells cooperate 
during the clinical course of colorectal cancer. Oncoimmunology 2014;3(8):e952197. 
 (14)  Mlecnik B, Tosolini M, Charoentong P et al. Biomolecular network reconstruction 
identifies T-cell homing factors associated with survival in colorectal cancer. 
Gastroenterology 2010;138(4):1429-40. 
 (15)  Hojo S, Koizumi K, Tsuneyama K et al. High-level expression of chemokine 
CXCL16 by tumor cells correlates with a good prognosis and increased tumor-
infiltrating lymphocytes in colorectal cancer. Cancer Res 2007;67(10):4725-31. 
 (16)  Grivennikov SI, Wang K, Mucida D et al. Adenoma-linked barrier defects and 
microbial products drive IL-23/IL-17-mediated tumour growth. Nature 
2012;491(7423):254-8. 
 (17)  Cespedes MV, Espina C, Garcia-Cabezas MA et al. Orthotopic microinjection of 
human colon cancer cells in nude mice induces tumor foci in all clinically relevant 
metastatic sites. Am J Pathol 2007;170(3):1077-85. 
 (18)  Castellarin M, Warren RL, Freeman JD et al. Fusobacterium nucleatum infection is 
prevalent in human colorectal carcinoma. Genome Res 2012;22(2):299-306. 
 (19)  Kostic AD, Gevers D, Pedamallu CS et al. Genomic analysis identifies association of 
Fusobacterium with colorectal carcinoma. Genome Res 2012;22(2):292-8. 
 (20)  Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. Cell Host Microbe 
2014;15(3):317-28. 
 (21)  Spranger S, Spaapen RM, Zha Y et al. Up-regulation of PD-L1, IDO, and T(regs) in 
the melanoma tumor microenvironment is driven by CD8(+) T cells. Sci Transl Med 
2013;5(200):200ra116. 
 (22)  Nagarsheth N, Peng D, Kryczek I et al. PRC2 Epigenetically Silences Th1-Type 
Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. Cancer Res 
2016;76(2):275-82. 
 (23)  Arthur JC, Perez-Chanona E, Muhlbauer M et al. Intestinal inflammation targets 
cancer-inducing activity of the microbiota. Science 2012;338(6103):120-3. 
 (24)  Rubinstein MR, Wang X, Liu W et al. Fusobacterium nucleatum promotes colorectal 
carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. 
Cell Host Microbe 2013;14(2):195-206. 
 (25)  Mima K, Nishihara R, Qian ZR et al. Fusobacterium nucleatum in colorectal 
carcinoma tissue and patient prognosis. Gut 2015. 
27 
 
 (26)  Gur C, Ibrahim Y, Isaacson B et al. Binding of the Fap2 protein of Fusobacterium 
nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell 
attack. Immunity 2015;42(2):344-55. 
 (27)  Saito T, Nishikawa H, Wada H et al. Two FOXP3(+)CD4(+) T cell subpopulations 
distinctly control the prognosis of colorectal cancers. Nat Med 2016;22(6):679-84. 
 (28)  Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial 
recognition shapes intestinal function. Nat Rev Immunol 2010;10(2):131-44. 
 
 
  
28 
 
Figure Legend 
Figure 1: CRC infiltration by T cells is associated with overexpression of defined 
chemokines. Expression of the genes encoding the indicated immune cell markers and 
chemokines was analyzed in 62 freshly excised CRC tissues and corresponding tumor-free 
colonic mucosa samples by qRT-PCR. A. Gene expression levels in CRC tissues (bold) and 
tumor-free colonic mucosa samples (gray) relative to GAPDH. Statistical significance was 
assessed by Wilcoxon signed rank test (*p<0.05; ***p<0.0001). B. Unsupervised hierarchical 
clustering of the expression of the indicated genes in individual CRC specimens as related to 
corresponding  tumor-free colonic tissues C. Expression of 38 chemokine genes (see Table 
S3) in tumors as related to corresponding tumor-free colonic tissues, according to their 
distribution within the different clusters.  
 
Figure 2: CRC infiltrating T cells express receptors binding overexpressed chemokines. 
Single cell suspensions obtained from freshly excised clinical CRC specimens were surface 
stained with fluorochrome labeled antibodies specific for CD8, or CD4, in combination with 
the indicated chemokine receptors. Intracellular staining for Foxp3 was then performed. For 
detection of IL-17 producing cells, cell suspensions were stimulated with PMA/Ionomycin, 
and after 4 hours they were fixed, permeabilized and intracellularly stained with antibodies 
specific for IL-17 and the indicated chemokine receptors. Percentages of positive cells within 
gated CD8+, CD4+ Foxp3-, CD4+ Foxp3+, CD4+ CXCR5+, and CD4+ IL-17+ cells are 
shown. Means and standard deviations are indicated by bars;  n.d., not detected, n.t., not 
tested. 
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Figure 3: Defined chemokine signatures are associated with CRC infiltration by 
individual immune cell subsets. Chemokines significantly associated with expression of 
immune cells markers were assigned a score calculated as detailed in Table S5. A heat map of 
score values is shown. 
 
Figure 4.  Tumor cells express genes encoding T cell recruiting chemokines. Expression 
of the indicated chemokine genes was evaluated by qRT-PCR in total CRC tissues and 
corresponding purified tumor cells (n=10), or in the indicated established CRC cell lines. 
Means are indicated by bars. Statistical significance was assessed by Mann Whitney test (* 
p<0.05). 
 
Figure 5. Gut bacteria-derived stimuli induce chemokine gene expression in CRC cells.  
CRC cell from LS180 cell line were treated with (A) LPS (1 μg/ml), Poly (I:C) (10 μg/ml), 
Flagellin (100 ng/ml), or FSL-1 (1 μg/ml), or (B) with the indicated heat-inactivated bacteria 
(bacteria: CRC cell ratio = 30:1). After four hours, expression levels of the indicated 
chemokine genes were analyzed by qRT-PCR, using GAPDH as reference gene. Cumulative 
data from three independent experiments are shown. Statistical significance was assessed by 
two-way ANOVA test (*=p<0.05). 
 
Figure 6. Exposure of tumor cells to gut flora promotes chemokine expression and T cell  
recruitment into CRC. A NSG mice were inoculated i.p. (n=17) or i.c. (n=66) with LS180 
cells (10^5 cells/mouse). Starting from day 10, a randomized group of mice inoculated i.p., 
(n=7) or i.c. (n=28), were treated with Ampicillin and Vancomycin for three weeks. On day 
31 xenografts were removed and expression levels of the indicated chemokine genes and of 
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16S were analyzed by qRT-PCR, using GAPDH gene as reference. Cumulative data from 
three independent experiments are shown. Statistical significance was assessed by two-way 
ANOVA test (*= p<0.05, **p<0.01, ***p<0.0001). B, C. NSG mice were inoculated with 
LS180 i.p. (n=11) or i.c. (n=14). On day 29, mice were adoptively transferred with equal 
numbers (5x10^6 cells/mouse) of human CFSE-labelled CRC-derived CD4+ and CD8+ T 
cells. After 48 hours, extent of human TIL migration into tumors was evaluated by flow 
cytometry. Cumulative data from two independent experiments performed with TILs derived 
from two different samples (P312, red, and P326, black) are shown. Statistical significance 
was assessed by one-way ANOVA test (***p<0.0001). 
 
Figure 7. Abundance of defined bacteria families correlates with T cell infiltration and 
improved clinical outcome in human CRCs. The gut flora composition of 27 primary CRC 
samples pre-assessed for density of CD3+ infiltrate (CD3high n=14, CD3low n=13) was 
analyzed by 16SrRNA sequencing. A.  Unsupervised hierarchical clustering of OTU 
abundances was performed using the hclust algoritm based on the Ward D2 method. B. 
Kaplan-Meier curves illustrating overall survival (OS) probability of patients included in 
clusters identified by hierarchical analysis. Statistical significance was assessed by log-rank 
test. C. Fold change (log2) of bacteria genera and families enriched in CD3high as compared 
to CD3low tumors are shown. Differential OTU analysis on normalized abundance counts 
was performed with  DESeq2 software (v1.12.4).Staistical significance (p<0.05) was assessed 
using a Wald test. 
 
Figure 8. Abundance of defined bacteria families correlates with expression of 
individual chemokines and T cell markers. Expression of genes encoding for the indicated 
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markers or chemokines was assessed in 27 CRC samples (see above) and Spearman 
correlations between all markers were calculated. Correlation matrixes illustrating major 
correlations found between expression of T cell markers and chemokine genes (A) to each 
other and (B) versus OUT abundances. Color and diameter of the spots are proportional to the 
calculated Spearman correlation coefficients as indicated in the blue to red bar. All r and 
corresponding p values are listed in Tables S9 and S10. 
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